# Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T

> **NCT01727154** · — · TERMINATED · sponsor: **Dendreon** · enrollment: 139 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** Sipuleucel-T

## Key facts

- **NCT ID:** NCT01727154
- **Lead sponsor:** Dendreon
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-10
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 139 (ACTUAL)
- **Why stopped:** Administrative reasons
- **Last updated:** 2019-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01727154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01727154, "Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01727154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*